Details for 2016823529
Up to date per 04.04.2026
Actions
Details for 2016823529
Granted/Registered
European Patent
31.10.2018 A
30.03.2022 B1
23.12.2015
US
201562387442 P
C07D 471/04 20060101AFI20170726BHEP
Owner
NEUROCRINE BIOSCIENCES, INC.6027 Edgewood Bend Court San Diego, CA 92130US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
MCGEE, Kevin82663 Marlow Road Eugene, OR 97405US
LI, Bin-FengA5-4F BioBay 218 Xinghu Street Suzhou Industrial Park 215123CN
Information about Fees